Novartis unloads U.S. assets at loss to bargain-hunting Aurobindo

New Novartis Chief Executive Vas Narasimhan has further reshaped the Swiss drugmaker, announcing on Thursday he is selling U.S. dermatology and generic pill assets to India’s Aurobindo Pharma Ltd for up to $1 billion.


Source: Business

Leave a Reply

Your email address will not be published. Required fields are marked *

twenty + four =